HomeCompareCSYJY vs PFE

CSYJY vs PFE: Dividend Comparison 2026

CSYJY yields 5.21% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PFE wins by $29.0K in total portfolio value· pulled ahead in Year 9
10 years
CSYJY
CSYJY
● Live price
5.21%
Share price
$3.40
Annual div
$0.18
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.6K
Annual income
$0.53
Full CSYJY calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — CSYJY vs PFE

📍 PFE pulled ahead of the other in Year 9

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCSYJYPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CSYJY + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CSYJY pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CSYJY
Annual income on $10K today (after 15% tax)
$442.90/yr
After 10yr DRIP, annual income (after tax)
$0.45/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, PFE beats the other by $22,319.45/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CSYJY + PFE for your $10,000?

CSYJY: 50%PFE: 50%
100% PFE50/50100% CSYJY
Portfolio after 10yr
$35.1K
Annual income
$13,129.63/yr
Blended yield
37.44%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

CSYJY
No analyst data
Altman Z
2.2
Piotroski
4/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CSYJY buys
0
PFE buys
0
No recent congressional trades found for CSYJY or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCSYJYPFE
Forward yield5.21%6.13%
Annual dividend / share$0.18$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%13.2%
Portfolio after 10y$20.6K$49.6K
Annual income after 10y$0.53$26,258.71
Total dividends collected$529.00$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CSYJY vs PFE ($10,000, DRIP)

YearCSYJY PortfolioCSYJY Income/yrPFE PortfolioPFE Income/yrGap
1$10,961$260.53$9,153$693.39+$1.8KCSYJY
2$11,861$133.44$8,593$849.25+$3.3KCSYJY
3$12,759$67.48$8,336$1,066.78+$4.4KCSYJY
4$13,686$33.92$8,437$1,384.80+$5.2KCSYJY
5$14,661$17.00$9,013$1,875.40+$5.6KCSYJY
6$15,696$8.51$10,306$2,680.72+$5.4KCSYJY
7$16,799$4.26$12,820$4,101.38+$4.0KCSYJY
8$17,977$2.13$17,673$6,826.70+$304.00CSYJY
9← crossover$19,236$1.06$27,543$12,591.86$8.3KPFE
10$20,583$0.53$49,560$26,258.71$29.0KPFE

CSYJY vs PFE: Complete Analysis 2026

CSYJYStock

CSE Global Limited, an investment holding company, provides integrated industrial automation, information technology, and intelligent transport solutions in the Asia Pacific, the Americas, Europe, the Middle East, and Africa. The company offers automation solutions, including process control, safety shutdown, fire and gas detection, supervisory control and data acquisition (SCADA), wellhead and subsea control, process skid, electrical drive and high/medium voltage, electrical protection and control, real-time information, and intelligent transport systems, as well as I&E construction and safe secure solutions. It also provides environmental solutions comprising multiple hearth furnaces, fluid bed incinerators, carbon and energy recovery systems, and rotary kiln incinerators. In addition, the company offers telecommunication solutions, including construction communications, fiber optic, microwave radio, conventional and trunked radio, and public address and general alarm systems; VSAT satellite communications, telephone, local and wide area, Internet protocol based, and SCADA and telemetry networks; and CCTV, access control, and FIDS systems. Further, it provides e-business integration, research and development, and computer system integration services; computer network systems; computer systems; infrastructure engineering services; plant and environmental engineering services; contracting resources and permanent placement; and two-way radio services. Additionally, the company distributes electrical engineering equipment; designs and installs high temperature thermal process and incineration systems; designs and develops water treatment and disposal technology; provides commercial building controls and automation services; and leases office and warehouse space. It serves oil and gas, infrastructure, and mining industries. CSE Global Limited was founded in 1985 and is headquartered in Singapore.

Full CSYJY Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this CSYJY vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CSYJY vs SCHDCSYJY vs JEPICSYJY vs OCSYJY vs KOCSYJY vs MAINCSYJY vs JNJCSYJY vs MRKCSYJY vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.